Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Saved in:
| Title: | Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. |
|---|---|
| Authors: | van Asselt ADI; Department of Health Sciences, University of Groningen, University Medical Center Groningen (UMCG), PO Box 30.001, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. a.d.i.van.asselt@umcg.nl.; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. a.d.i.van.asselt@umcg.nl., Armstrong N; Kleijnen Systematic Reviews Ltd, York, UK., Kimman M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Peeters A; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands., McDermott K; Kleijnen Systematic Reviews Ltd, York, UK., Stirk L; Kleijnen Systematic Reviews Ltd, York, UK., Ahmadu C; Kleijnen Systematic Reviews Ltd, York, UK., Govers TM; Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands., Hoentjen F; Division of Gastroenterology, University of Alberta, Edmonton, AB, Canada.; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, The Netherlands., Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands., Grimm SE; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2023 Mar; Vol. 41 (3), pp. 239-251. Date of Electronic Publication: 2023 Feb 01. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
